“…Secondary metabolites were isolated from the fermentation broth of the endophytic fungus Xylaria sp.SYPF 8246, including four new compounds, xylarianins A-D 379-382 (Figure 12), three new natural products, 6-methox-ycarbonyl-2 -methyl-3,5,4 ,6 -tetramethoxy-diphenyl ether 383 (Figure 12), 2-chlor-6-methoxycarbonyl-2 -rnethyl-3,5,4 ,6 -tetramethoxy-diphenyl ether 384 (Figure 12), and 2-chlor-4 -hydroxy-6-methoxy carbonyl-2 -methyl-3,5,6 -trimethoxy-diphenyl ether 385 (Figure 12) [94]. Bysspectin A 386 (Figure 12), a polyketide-derived octaketide dimer with a novel carbon skeleton, and two new precursor derivatives, bysspectins B and C 387-388 (Figure 12), were obtained from an organic extract of the endophytic fungus Byssochlamys spectabilis that had been isolated from a leaf tissue of the traditional Chinese medicinal plant Edgeworthia chrysantha [124]. Fusarithioamide B 389 (Figure 12), a new aminobenzamide derivative with unprecedented carbon skeleton was separated from Fusarium chlamydosporium EtOAc extract isolated from Anvillea garcinii (Burm.f.)…”